Do PPIs Increase the Risk for Renal Damage or Mortality?
Dr Tejas Desai looks into the latest analysis on the potential adverse effects of proton pump inhibitors and asks whether de-escalation measures should be implemented.
Related Articles
Insulin Remains the Top Choice for Gestational Diabetes
Results from a Dutch study reinforced insulin’s status as the leading treatment for gestational diabetes, particularly when compared with a sequential oral medication approach that…
Obesity Medications: Who Needs Priority Access
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.
Most Antivirals Have Little Benefit for Patients With Nonsevere Influenza
Most commonly used drugs don’t reduce symptoms, hospitalizations, or mortality rates for low- and high-risk patients.
Feeling Like an Imposter as a Med Student? You’re Not Alone
More than 70% of people suffer from imposter syndrome, and a lot have learned to move past it.
What You Need to Know About Pregnancy and IBD
Having active disease (vs disease in remission) was associated with a higher risk for gestational diabetes and fever.
Q&A: Are You Sure the Diagnosis Is IgA Nephropathy?
Arnold B. Alper, MD, discusses the IgA nephropathy differential diagnosis.
Clinical Perspectives on the Best Approach to First-Line Therapy in Unresectable HCC
Do you use combination therapy for patients with unresectable hepatocellular carcinoma (HCC)?
Alcohol: How Much Is Too Much?
Dr Charles Vega asks colleagues how they screen for excessive alcohol use among primary care patients.
Clinical Perspectives on the Best Approach to First-Line Therapy in Unresectable HCC
Do you use combination therapy for patients with unresectable hepatocellular carcinoma (HCC)?
Clinical Perspectives on the Best Approach to First-Line Therapy in Unresectable HCC
Do you use combination therapy for patients with unresectable hepatocellular carcinoma (HCC)?